Tumor-specific T cells signal tumor destruction via the lymphotoxin β receptor
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Tumor-specific T cells signal tumor destruction via the lymphotoxin β receptor ; volume:5 ; number:1 ; day:13 ; month:3 ; year:2007 ; pages:1-12 ; date:12.2007
Journal of translational medicine ; 5, Heft 1 (13.3.2007), 1-12, 12.2007
- Urheber
- Beteiligte Personen und Organisationen
-
van den Engel, Natasja K.
Poehlein, Christian H.
Hatz, Rudolf A.
Fox, Bernard A.
Hu, Hong-Ming
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-5-14
- URN
-
urn:nbn:de:1111-2016041431810
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 09:01 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Winter, Hauke
- van den Engel, Natasja K.
- Poehlein, Christian H.
- Hatz, Rudolf A.
- Fox, Bernard A.
- Hu, Hong-Ming
- SpringerLink (Online service)
Ähnliche Objekte (12)
Tumor‐specific CD 4 + T cells maintain effector and memory tumor‐specific CD 8 + T cells
Neuropilin-1 drives tumor-specific uptake of chlorotoxin
Natural and revolutionary tumor-specific T-cell therapy
Redirecting oncolytic adenovirus-specific T cells by a tumor-specific T cell receptor for therapy of solid tumors
Generation of tumor-specific NK cells through NCR1 promoter controlled chimeric antigen receptor expression
Tumor microenvironment-derived monoacylglycerol lipase provokes tumor-specific immune responses and lipid profiles
Consistency-based detection of potential tumor-specific deletions in matched normal/tumor genomes
Recognition of Transmembrane Protein 39A as a Tumor-Specific Marker in Brain Tumor
Sonosynthetic Cyanobacteria Oxygenation for Self‐Enhanced Tumor‐Specific Treatment
Design and Evaluation of Tumor‐Specific Dendrimer Epigenetic Therapeutics
Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation
Identification and validation of tumor-specific T cell receptors from tumor infiltrating lymphocytes using tumor organoid co-cultures
Tumor‐specific CD 4 + T cells maintain effector and memory tumor‐specific CD 8 + T cells
Neuropilin-1 drives tumor-specific uptake of chlorotoxin
Natural and revolutionary tumor-specific T-cell therapy
Redirecting oncolytic adenovirus-specific T cells by a tumor-specific T cell receptor for therapy of solid tumors
Generation of tumor-specific NK cells through NCR1 promoter controlled chimeric antigen receptor expression
Tumor microenvironment-derived monoacylglycerol lipase provokes tumor-specific immune responses and lipid profiles
Consistency-based detection of potential tumor-specific deletions in matched normal/tumor genomes
Recognition of Transmembrane Protein 39A as a Tumor-Specific Marker in Brain Tumor
Sonosynthetic Cyanobacteria Oxygenation for Self‐Enhanced Tumor‐Specific Treatment
Design and Evaluation of Tumor‐Specific Dendrimer Epigenetic Therapeutics
Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation
Identification and validation of tumor-specific T cell receptors from tumor infiltrating lymphocytes using tumor organoid co-cultures
Tumor‐specific CD 4 + T cells maintain effector and memory tumor‐specific CD 8 + T cells
Neuropilin-1 drives tumor-specific uptake of chlorotoxin
Natural and revolutionary tumor-specific T-cell therapy
Redirecting oncolytic adenovirus-specific T cells by a tumor-specific T cell receptor for therapy of solid tumors
Generation of tumor-specific NK cells through NCR1 promoter controlled chimeric antigen receptor expression
Tumor microenvironment-derived monoacylglycerol lipase provokes tumor-specific immune responses and lipid profiles
Consistency-based detection of potential tumor-specific deletions in matched normal/tumor genomes
Recognition of Transmembrane Protein 39A as a Tumor-Specific Marker in Brain Tumor
Sonosynthetic Cyanobacteria Oxygenation for Self‐Enhanced Tumor‐Specific Treatment
Design and Evaluation of Tumor‐Specific Dendrimer Epigenetic Therapeutics
Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation